AdaptResponse Clinical Trial
AdaptResponse Clinical Trial
The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) conduction and left bundle branch block (LBBB).
Inclusion Criteria:
Exclusion Criteria:
Bernau bei Berlin, Germany
Homburg/Saar, Germany
Mitaka-Shi, Japan
Shimonoseki-Shi, Japan
Suita-Shi, Japan
Katowice, Poland
Moscow, Russia
Novosibirsk, Russia
Liverpool, United Kingdom